Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
This page offers a quick comparison of Index Fund and Target Date for retirement, with tips on matching your plans and risk tolerance.
24,517 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
The eVTOL craze mixes hype with real engineering, regulatory hurdles, and capital burn. Here's why I wouldn't touch t...
The NHL is evaluating a Texas expansion with Dan Friedkin, potentially in Houston or Austin. A six-month term sheet o...
Bitcoin miners face intensifying cash-flow pressure as revenue falls short of production costs for many operators. Th...
SpaceX (SPCX) has fallen about 30% from its peak while planning a large debt raise. This guide breaks down what the d...
In a choppy market, one defense contractor shines as a rare dividend stock built for downturns. Its government-backed...
A long standing trading rule is gone, and it could change how millions of small investors trade. This shift may lift ...
Markets confront a rebalanced risk outlook as Iran signals it may push for nuclear concessions to survive. Investors ...
As AI builds out more data centers, the U.S. power grid faces mounting strain. HPE’s warning of a looming 19 gigawatt...
MicroStrategy's crypto treasury, dubbed Strategy, remains substantially underwater as Saylor signals another bitcoin ...
Strategy pauses bitcoin buys as the firm unveils a $1 billion digital credit repurchase program, boosting cash reserv...
Ripple's XRP Ledger is moving toward an on-chain lending layer. This article explains how the ledger's 'missing layer...